# EX-02-Cross-Platform-Prompting-Evaluating-Diverse-Techniques-in-AI-Powered-Text-Summarization

## AIM
To design prompts using different prompt structures.

## Scenario:
Students should practice with any one specific application like - Text Summarization or relevant with Project works... From the Basic prompts to upgrade that up to Final out how user defined that.

Basic Prompt
Role Prompt
Context Prompt
Constraint Prompt
Output Format Prompt

## AI Tools required:
ChatGPT, Gemini

## Article

**Polypharmacy Side-Effects Risk Predictor using Quantum Machine Learning**

Polypharmacy Side-Effects Risk Predictor using Quantum Machine Learning (QML) is an advanced healthcare decision-support system designed to predict the likelihood of adverse drug reactions (ADRs) that may occur when a patient takes multiple medications simultaneously. Polypharmacy, commonly defined as the regular use of five or more medications, has become increasingly common due to the growing number of elderly individuals and patients suffering from chronic diseases such as diabetes, hypertension, cardiovascular disorders, kidney disease, arthritis, and cancer. While multiple medications are often necessary to manage these conditions, they significantly increase the risk of harmful drug–drug interactions, medication errors, toxicity, allergic reactions, and severe side effects that can lead to hospitalization or even death. Traditional methods of identifying these interactions rely heavily on manual clinical assessment and predefined drug interaction databases, which may not accurately capture complex relationships among patient characteristics, disease conditions, and medication combinations. Therefore, an intelligent prediction system capable of analyzing multiple clinical factors simultaneously is essential for improving medication safety.

The proposed system utilizes Quantum Machine Learning, an emerging field that combines the computational power of quantum computing with artificial intelligence, to enhance predictive accuracy for complex healthcare problems. Quantum computers process information using quantum bits (qubits), which can exist in multiple states simultaneously through superposition and exploit entanglement to represent highly complex relationships within data. These properties enable quantum algorithms to identify patterns that may be difficult for classical machine learning models to detect, particularly in high-dimensional medical datasets. By leveraging these capabilities, the system aims to improve the prediction of adverse drug reactions and support safer clinical decision-making.

The system begins by collecting comprehensive patient information from electronic health records and publicly available medical datasets. The input features include demographic information such as age, gender, weight, and body mass index (BMI); medical history including chronic diseases, previous hospitalizations, surgeries, and existing health conditions; laboratory values such as blood glucose, liver function, kidney function, and cholesterol levels; medication information including drug names, dosage, frequency, route of administration, treatment duration, and the total number of medications currently prescribed. Additional factors such as previous allergic reactions, genetic predisposition (if available), lifestyle habits including smoking and alcohol consumption, and known drug sensitivities can also be incorporated to improve prediction accuracy.

Before model training, the collected data undergoes an extensive preprocessing stage. Missing values are handled using suitable imputation techniques, duplicate records are removed, and noisy or inconsistent entries are cleaned to improve data quality. Numerical features are normalized or standardized, while categorical variables such as gender, disease categories, and medication names are converted into machine-readable representations using encoding techniques like One-Hot Encoding or Label Encoding. Feature engineering techniques are applied to generate additional useful variables, such as the total number of medications, interaction severity scores, cumulative dosage, and disease complexity index. Feature selection methods such as Principal Component Analysis (PCA) or Recursive Feature Elimination (RFE) may also be employed to reduce dimensionality and improve computational efficiency.

After preprocessing, the data is divided into training, validation, and testing datasets. Since current quantum computers have limited qubits and are affected by noise, dimensionality reduction techniques are often applied before encoding classical data into quantum states. The selected features are then mapped into quantum circuits using quantum feature maps such as Angle Encoding, Amplitude Encoding, or Basis Encoding. These encoded quantum states are processed using parameterized quantum circuits that serve as the foundation for Quantum Machine Learning models.

The project can implement different Quantum Machine Learning algorithms depending on the experimental setup. A Variational Quantum Classifier (VQC) uses trainable quantum circuits to classify patients into predefined risk categories. A Quantum Neural Network (QNN) combines quantum circuits with neural network architectures to capture highly nonlinear relationships within medical data. Other hybrid quantum-classical approaches can also be explored, where quantum circuits perform feature extraction while classical neural networks perform the final classification. The predicted output may consist of multiple categories such as Low Risk, Medium Risk, and High Risk, or a binary prediction indicating whether an adverse drug reaction is likely or unlikely to occur.

To evaluate the effectiveness of the proposed model, its performance is compared with well-established classical machine learning algorithms such as Logistic Regression, Decision Tree, Random Forest, Support Vector Machine (SVM), XGBoost, Gradient Boosting, and Artificial Neural Networks (ANN). Performance metrics include Accuracy, Precision, Recall, F1-Score, Sensitivity, Specificity, Area Under the ROC Curve (AUC-ROC), Matthews Correlation Coefficient (MCC), and Confusion Matrix analysis. Cross-validation techniques can be employed to ensure the robustness and generalization capability of the models. Statistical comparisons between classical and quantum approaches help determine whether QML provides measurable improvements in predictive performance.

Several publicly available biomedical datasets can be used to develop and evaluate the system. The MIMIC-IV dataset provides anonymized intensive care patient records, including diagnoses, laboratory results, medications, and clinical outcomes. The SIDER dataset contains comprehensive information about marketed drugs and their known side effects. DrugBank offers detailed information regarding drug properties, mechanisms, pharmacological interactions, and drug–drug interaction networks. Additional resources such as FAERS (FDA Adverse Event Reporting System), OMOP Common Data Model datasets, and open clinical repositories can further enrich the training data.

The proposed architecture consists of multiple interconnected modules. The Data Collection Module gathers patient records and medication information. The Data Preprocessing Module performs cleaning, transformation, normalization, and feature engineering. The Feature Encoding Module converts classical medical data into quantum representations suitable for quantum circuits. The Quantum Machine Learning Module trains and optimizes the Variational Quantum Classifier or Quantum Neural Network. The Risk Prediction Module generates the probability of adverse side effects and classifies patients into different risk levels. Finally, the Decision Support Module presents prediction results through a user-friendly interface that can assist healthcare professionals during prescription planning.

The system offers numerous advantages to modern healthcare. It enables early identification of high-risk medication combinations before treatment begins, reducing preventable adverse drug reactions and improving patient safety. Physicians can make more informed prescribing decisions based on predicted risk levels, while pharmacists can verify prescriptions more efficiently. Hospitals may reduce emergency admissions, medication-related complications, and treatment costs associated with adverse drug events. The model also contributes to personalized medicine by tailoring treatment decisions according to each patient's medical profile rather than relying solely on generalized clinical guidelines.

Despite its advantages, several challenges remain. Current quantum hardware is still in the Noisy Intermediate-Scale Quantum (NISQ) era, meaning available quantum devices contain relatively few qubits and are susceptible to noise and decoherence. Access to large, high-quality, and well-annotated clinical datasets may be limited because of patient privacy regulations and ethical concerns. Encoding large-scale medical datasets into quantum circuits remains computationally challenging, and hybrid quantum-classical approaches are currently more practical than fully quantum solutions. Furthermore, extensive clinical validation is required before such systems can be integrated into real-world healthcare environments.

Future enhancements can significantly improve the practicality and impact of the proposed system. The model can be integrated with Electronic Health Records (EHRs) to enable automatic retrieval of patient information and real-time risk prediction during clinical consultations. Explainable Artificial Intelligence (XAI) techniques such as SHAP or LIME can be incorporated to provide transparent explanations for model predictions, increasing clinician trust and regulatory acceptance. Personalized dosage recommendation modules can suggest safer drug dosages based on individual patient characteristics and predicted risk levels. Continuous learning mechanisms can update the model as new clinical data becomes available, improving prediction accuracy over time. Deployment on cloud-based quantum computing platforms such as IBM Quantum, Amazon Braket, or Microsoft Azure Quantum would allow healthcare institutions to access quantum resources without investing in expensive hardware. Mobile and web-based applications can also be developed to provide clinicians with instant medication safety assessments during routine practice.

In conclusion, the Polypharmacy Side-Effects Risk Predictor using Quantum Machine Learning represents an innovative intersection of quantum computing, artificial intelligence, and precision healthcare. By combining patient demographics, medical history, laboratory findings, medication information, and advanced quantum algorithms, the proposed system aims to accurately predict adverse drug reactions before they occur. The project has the potential to improve prescribing practices, enhance patient safety, reduce healthcare costs, support personalized medicine, and demonstrate the practical application of Quantum Machine Learning in solving real-world medical challenges. Although quantum computing technology is still evolving, hybrid quantum-classical solutions offer a promising pathway toward the next generation of intelligent clinical decision support systems.



## Prompts
### Basic Prompt

Develop a Quantum Machine Learning-based system to predict the risk of polypharmacy side effects by analyzing patient information, medical history, medication details, dosage, treatment duration, and drug interactions, and classify patients into Low, Medium, or High risk to support safer clinical decision-making.

### Role Prompt

You are a Quantum Machine Learning Engineer and Healthcare AI expert specializing in medical data analysis, drug–drug interaction prediction, and clinical decision support systems. Your task is to design and develop a Quantum Machine Learning-based Polypharmacy Side-Effects Risk Predictor that accurately predicts adverse drug reaction risks using patient and medication data.

### Context Prompt

Polypharmacy increases the risk of adverse drug reactions due to multiple medications. Build a Quantum Machine Learning system that analyzes patient and medication data to predict side-effect risk and classify patients as Low, Medium, or High risk for safer clinical decision-making.

### Constraint Prompt

Use publicly available datasets, implement a Quantum Machine Learning model (VQC or QNN), compare it with classical machine learning models, ensure high prediction accuracy, and provide clear, interpretable risk classifications (Low, Medium, High).

### Output Format Prompt (Final Prompt)

Provide the output in the following format: Project Overview, Objectives, Dataset, Methodology, Quantum Model, Classical Model Comparison, System Architecture, Prediction Output (Low/Medium/High Risk), Evaluation Metrics, Advantages, Future Scope, and Conclusion.



## Output
 

## Conclusion

Thus, the experiment shows that prompt engineering improves AI-generated responses for the Polypharmacy Side-Effects Risk Predictor using Quantum Machine Learning. Google Gemini generated more detailed technical outputs, while ChatGPT provided clear and concise explanations. Overall, the Output Format Prompt produced the best and most well-structured results.

